Out-of-Pocket Costs for Infliximab and Its Biosimilar for Rheumatoid Arthritis Under Medicare Part D.

2018
https://researcherprofiles.org/profile/26183722
30193264
Yazdany J, Dudley RA, Lin GA, Chen R, Tseng CW